Participants diagnosed with insomnia disorder according to the criteria defined by the DSM-V (1) and who report sleep maintenance disorder;
Participants who agree not to use alcoholic beverages during the entire treatment period (6 weeks).
You may not be if
Participants with known hypersensitivity to the active ingredients used during the trial or who have exhibited complex sleep behavior after using them;
Participants with a history of alcohol, substance, or illicit drug abuse disorder in the last 2 years;
Women who are pregnant or breastfeeding, as well as women who have a positive result on a pregnancy test (β-hCG) during the screening period of the trial;